SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* ALBAN CARLOS (Last) (First) (Middle) 1 N. WAUKEGAN ROAD (Street) NORTH CHICAGO IL 60064 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol AbbVie Inc. [ ABBV ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) EVP, Commercial Operations
	3. Date of Earliest Transaction (Month/Day/Year) 05/01/2013
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, $0.01 par value	05/01/2013		M		35,700	A	$27.294	182,535	D
Common stock, $0.01 par value	05/01/2013		M		33,900	A	$28.8628	216,435	D
Common stock, $0.01 par value	05/01/2013		M		17,700	A	$28.1251	234,135	D
Common stock, $0.01 par value	05/01/2013		M		21,000	A	$26.8472	255,135	D
Common stock, $0.01 par value	05/01/2013		M		34,600	A	$28.3122	289,735	D
Common stock, $0.01 par value	05/01/2013		S		28,122	D	$45.6837	261,613	D
Common stock, $0.01 par value	05/01/2013		S		27,320	D	$45.6648	234,293	D
Common stock, $0.01 par value	05/01/2013		S		30,550	D	$45.6768	203,743	D
Common stock, $0.01 par value	05/01/2013		S		27,664	D	$45.6797	176,079	D
Common stock, $0.01 par value								40,442(1)	I	Maria Cristina Alban 2007 Declaration of Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)(2)	$27.294	05/01/2013		M			35,700	02/16/2010	02/15/2017	Common stock	35,700	$0	0	D
Option (right to buy)(2)	$28.8628	05/01/2013		M			33,900	02/15/2011	02/14/2018	Common stock	33,900	$0	0	D
Option (right to buy)(2)	$28.1251	05/01/2013		M			17,700	02/20/2012	02/19/2019	Common stock	17,700	$0	0	D
Option (right to buy)(2)	$26.8472	05/01/2013		M			21,000	10/15/2012	10/14/2019	Common stock	21,000	$0	0	D
Option (right to buy)(2)	$28.3122	05/01/2013		M			34,600	02/19/2013	02/18/2020	Common stock	34,600	$0	0	D

Explanation of Responses:

1. Held in the Maria Christina Alban 2007 Declaration of Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.

2. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These exercises were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

	Steven L. Scrogham, attorney-in-fact for Carlos Alban	05/03/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.